Skip to main content
Atrás
MBX logo

MBX Biosciences, Inc. Common Stock

Calidad de datos: 100%
MBX
NASDAQ Healthcare Biotechnology
$28.14
▼ $0.54 (-1.88%)
Cap. Mercado: 945.31M
Rango del Día
$28.05 $29.88
Rango de 52 Semanas
$4.81 $44.89
Volumen
538,872
Promedio 50D / 200D
$35.10 / $22.42
Cierre Anterior
$28.68

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Healthcare (626 pares)

Métrica Acción Mediana del Sector
P/E -10.9 0.4
P/B 2.6 2.9
ROE % -27.8 3.7
Net Margin % 3.8
Rev Growth 5Y % 10.0
D/E 0.0 0.2

Puntos Clave

Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -81.88M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-27.76%
ROIC-19.89%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
0.00
Current Ratio24.62
Interest Coverage0.00

Valoración

P/E Ratio
-10.87
P/B Ratio2.56
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -86.97M
ROE -27.76% ROA -22.58%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -81.88M
ROIC -19.89% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.00 Current Ratio 24.62
Interest Coverage 0.00 Dividend Yield 0.00%
Valuation
P/E Ratio -10.87 P/B Ratio 2.56
P/S Ratio N/A PEG Ratio -0.46
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 945.31M Enterprise Value 870.62M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue 0.0 0.0 0.0 0.0
Net Income -86.97M -61.92M -32.56M -26.14M
EPS (Diluted) -2.38 -1.85 -1.02 -0.82
Gross Profit -248,000.0 0.0 0.0 0.0
Operating Income -98.06M -68.19M -35.31M -25.16M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 385.14M 268.54M 84.18M 45.10M
Total Liabilities 15.92M 11.09M 156.65M 87.70M
Shareholders' Equity 369.22M 257.44M -72.47M -42.61M
Total Debt 596,000.0 171,000.0 324,000.0 461,000.0
Cash & Equivalents 75.29M 49.35M 30.52M 24.21M
Current Assets 381.54M 267.29M 83.47M 44.21M
Current Liabilities 15.50M 11.05M 3.93M 3.43M